Launch discount: 10 % off everything with code LAUNCH10
Glow Blend (Mini)

Glow Blend (Mini)

The small edition of Glow Blend: GHK-Cu and BPC-157 at the core, complemented by minor shares of other regeneration peptides, intended for skin models.

Strength
Pack size
Quantity
Final price

On the shelf means out within 48 hours. No joke.

Shipped within 48 hours · EU only · Crypto or cash on delivery · Research use only

Overview

Glow Blend Mini is a compact formulation of several peptides for skin and ageing research. The "Mini" refers to the total amount of peptide per vial: it is lower than in the large Glow Blend variant, which suits the mixture to shorter experimental series or to approaches working with smaller total amounts.

Two molecules form the core:

  • GHK-Cu, the copper tripeptide: in skin models it is linked with stimulated collagen formation and with the regulation of genes involved in tissue repair.
  • BPC-157, the pentadecapeptide: in preclinical work it stands for the repair of connective tissue.

Smaller shares of further peptides from the regeneration and anti-ageing field are added. TB-500, for instance, is named as a possible addition; it promotes cell mobility by mobilising actin.

The logic of the mixture: collagen build-up and gene regulation (GHK-Cu), connective tissue repair (BPC-157) and cell migration (further components) are brought together in one solution instead of being prepared separately. For questions around skin structure and ageing this covers several of the relevant mechanisms at once.

Keep in mind that the evidence hangs on the individual peptides. There are no dedicated studies of the exact mixture; its action is inferred from research on the components. If you look for evidence, you will find it on GHK-Cu, on BPC-157 and on thymosin beta-4, not on the combination.

Risk notes

The ingredients, GHK-Cu, BPC-157 and the complementary peptides, each show a mild profile in the preclinical literature. There is no separate safety assessment of the mixture in this composition, and long-term human studies are missing for the individual peptides as well.

  • Injection site: redness, a feeling of pressure or a brief irritation with subcutaneous administration, the most frequent observation.
  • Copper: the GHK-Cu share can slightly intensify local irritation at the injection site compared with copper-free peptide solutions.
  • Circulation: isolated reports mention brief tiredness or a sensation of warmth after administration.

This summary is no substitute for medical advice.

Sources

All products are intended for in-vitro research and laboratory use only. Not for human or veterinary use, not for diagnosis or treatment. The texts summarise published research and are no medical advice.